ArticleCancers2022

Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B.

Ming-Whei Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.